Published in Eur J Biochem on August 15, 1996
Fundamental aspects of protein-protein association kinetics. Chem Rev (2009) 3.43
Structural biology of shared cytokine receptors. Annu Rev Immunol (2009) 2.27
Electrostatic rate enhancement and transient complex of protein-protein association. Proteins (2008) 1.89
Tuning sensitivity to IL-4 and IL-13: differential expression of IL-4Ralpha, IL-13Ralpha1, and gammac regulates relative cytokine sensitivity. J Exp Med (2008) 1.83
BMP-2 antagonists emerge from alterations in the low-affinity binding epitope for receptor BMPR-II. EMBO J (2000) 1.55
Rate theories for biologists. Q Rev Biophys (2010) 1.44
Receptor oligomerization and beyond: a case study in bone morphogenetic proteins. BMC Biol (2009) 1.12
Poisson-Boltzmann calculations of nonspecific salt effects on protein-protein binding free energies. Biophys J (2007) 1.10
Structural and biophysical studies of the human IL-7/IL-7Ralpha complex. Structure (2009) 1.07
Prediction of salt and mutational effects on the association rate of U1A protein and U1 small nuclear RNA stem/loop II. J Phys Chem B (2007) 1.03
Site2 binding energetics of the regulatory step of growth hormone-induced receptor homodimerization. Protein Sci (2003) 0.98
Remarkably fast coupled folding and binding of the intrinsically disordered transactivation domain of cMyb to CBP KIX. J Phys Chem B (2013) 0.97
A modular interface of IL-4 allows for scalable affinity without affecting specificity for the IL-4 receptor. BMC Biol (2006) 0.95
Association and dissociation kinetics of colicin E3 and immunity protein 3: convergence of theory and experiment. Protein Sci (2003) 0.94
Structural insights into the common γ-chain family of cytokines and receptors from the interleukin-7 pathway. Immunol Rev (2012) 0.91
Overexpression of interleukin-4 in lungs of mice impairs elimination of Histoplasma capsulatum. Infect Immun (2003) 0.89
Induction of oxazolone-mediated features of atopic dermatitis in NOD-scid IL2Rγ(null) mice engrafted with human peripheral blood mononuclear cells. Dis Model Mech (2012) 0.85
Effects of the geometry of the immunological synapse on the delivery of effector molecules. Biophys J (2004) 0.84
Electrostatic interactions in the binding pathway of a transient protein complex studied by NMR and isothermal titration calorimetry. J Biol Chem (2014) 0.82
De novo design of an IL-4 antagonist and its structure at 1.9 A. Proc Natl Acad Sci U S A (2005) 0.81
A biosensor study indicating that entropy, electrostatics, and receptor glycosylation drive the binding interaction between interleukin-7 and its receptor. Biochemistry (2010) 0.81
NOD-scid IL2R γnull mice engrafted with human peripheral blood mononuclear cells as a model to test therapeutics targeting human signaling pathways. J Transl Med (2013) 0.79
Predicting Protein-protein Association Rates using Coarse-grained Simulation and Machine Learning. Sci Rep (2017) 0.75
The imported preprotein of the proteolipid subunit of the mitochondrial ATP synthase from Neurospora crassa. Molecular cloning and sequencing of the mRNA. EMBO J (1982) 2.76
Mitochondrial genes and translation products. Annu Rev Biochem (1979) 2.29
Crystal structure of the BMP-2-BRIA ectodomain complex. Nat Struct Biol (2000) 2.15
Bone morphogenetic protein receptor complexes on the surface of live cells: a new oligomerization mode for serine/threonine kinase receptors. Mol Biol Cell (2000) 2.08
Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity. Eur J Biochem (1996) 1.98
Nucleotide sequence of the cloned mRNA and gene of the ADP/ATP carrier from Neurospora crassa. EMBO J (1984) 1.75
Processing peptidase of Neurospora mitochondria. Two-step cleavage of imported ATPase subunit 9. Eur J Biochem (1984) 1.73
Translational initiation frequency of atp genes from Escherichia coli: identification of an intercistronic sequence that enhances translation. EMBO J (1985) 1.67
The dicyclohexylcarbodiimide-binding protein of the mitochondrial ATPase complex from Neurospora crassa and Saccharomyces cerevisiae. Identification and isolation. Eur J Biochem (1979) 1.58
BMP-2 antagonists emerge from alterations in the low-affinity binding epitope for receptor BMPR-II. EMBO J (2000) 1.55
Crystal structure of human bone morphogenetic protein-2 at 2.7 A resolution. J Mol Biol (1999) 1.53
Identification of amino-acid substitutions in the proteolipid subunit of the ATP synthase from dicyclohexylcarbodiimide-resistant mutants of Escherichia coli. Eur J Biochem (1980) 1.49
The proton conducting F0-part of bacterial ATP synthases. Biochim Biophys Acta (1984) 1.49
Crystal structure of the interleukin-4/receptor alpha chain complex reveals a mosaic binding interface. Cell (1999) 1.48
The primary structure of the iron-sulfur subunit of ubiquinol-cytochrome c reductase from Neurospora, determined by cDNA and gene sequencing. Eur J Biochem (1985) 1.46
Identification of two products of mitochondrial protein synthesis associated with mitochondrial adenosine triphosphatase from Neurospora crassa. Eur J Biochem (1975) 1.35
Conversion of human interleukin-4 into a high affinity antagonist by a single amino acid replacement. EMBO J (1992) 1.35
N,N'-dicyclohexylcarbodiimide binds specifically to a single glutamyl residue of the proteolipid subunit of the mitochondrial adenosinetriphosphatases from Neurospora crassa and Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1980) 1.34
Dual role of the IL-12/IFN-gamma axis in the development of autoimmune myocarditis: induction by IL-12 and protection by IFN-gamma. J Immunol (2001) 1.31
Nucleotide sequence and transcription of the fbc operon from Rhodopseudomonas sphaeroides. Evaluation of the deduced amino acid sequences of the FeS protein, cytochrome b and cytochrome c1. Eur J Biochem (1986) 1.29
A mixed-charge pair in human interleukin 4 dominates high-affinity interaction with the receptor alpha chain. Proc Natl Acad Sci U S A (1997) 1.28
The proteolipid of a mutant ATPase from Escherichia coli defective in H+-conduction contains a glycine instead of the carbodiimide-reactive aspartyl residue. FEBS Lett (1980) 1.26
Mitochondrial porin of Neurospora crassa: cDNA cloning, in vitro expression and import into mitochondria. EMBO J (1987) 1.25
Design of human interleukin-4 antagonists inhibiting interleukin-4-dependent and interleukin-13-dependent responses in T-cells and B-cells with high efficiency. Eur J Biochem (1994) 1.20
Biogenesis of mitochondrial ATPase. Biochim Biophys Acta (1977) 1.19
An Asp-Asn substitution in the proteolipid subunit of the ATP-synthase from Escherichia coli leads to a non-functional proton channel. FEBS Lett (1982) 1.18
Low-grade B cell lymphomas of mucosa-associated lymphoid tissue (MALT-type) require CD40-mediated signaling and Th2-type cytokines for in vitro growth and differentiation. Am J Pathol (1997) 1.15
IL-4 enhances proliferation and mediator release in mature human mast cells. Proc Natl Acad Sci U S A (1999) 1.15
Two distinct functional sites of human interleukin 4 are identified by variants impaired in either receptor binding or receptor activation. EMBO J (1993) 1.14
Cooperativity of binding epitopes and receptor chains in the BMP/TGFbeta superfamily. Biol Chem (2001) 1.13
Enforced covalent trimerization increases the activity of the TNF ligand family members TRAIL and CD95L. Cell Death Differ (2007) 1.11
Isolation of recombinant BMP receptor IA ectodomain and its 2:1 complex with BMP-2. FEBS Lett (2000) 1.10
Enhancement of translational efficiency by the Escherichia coli atpE translational initiation region: its fusion with two human genes. Gene (1986) 1.10
Cycloheximide resistant incorporation of amino acids into a polypeptide of the cytochrome oxidase of Neurospora crassa. Eur J Biochem (1971) 1.09
Amino acid sequence of a new mitochondrially synthesized proteolipid of the ATP synthase of Saccharomyces cerevisiae. EMBO J (1984) 1.09
Incorporation in vivo of 14C-labelled amino acids into the proteins of mitochondrial ribosomes from Neurospora crassa sensitive to cycloheximide and insensitive to Chloramphenicol. Eur J Biochem (1969) 1.07
Products of mitochondrial protein synthesis in Neurospora crassa. Determination of equimolar amounts of three products in cytochrome oxidase on the basis of amino-acid analysis. Eur J Biochem (1973) 1.07
The topology of the proton translocating F0 component of the ATP synthase from E. coli K12: studies with proteases. EMBO J (1983) 1.07
Type III TGF-beta receptor-independent signalling of TGF-beta2 via TbetaRII-B, an alternatively spliced TGF-beta type II receptor. EMBO J (2001) 1.05
Biochemical and biophysical characterization of refolded Drosophila DPP, a homolog of bone morphogenetic proteins 2 and 4. J Biol Chem (1998) 1.05
Mutant proteins of human interleukin 2. Renaturation yield, proliferative activity and receptor binding. Eur J Biochem (1989) 1.04
Mitochondrial ATPase complex from Neurospora crassa. Methods Enzymol (1979) 1.04
Preparation of Neurospora crassa mitochondria. Methods Enzymol (1979) 1.03
b-Type cytochromes. Annu Rev Biochem (1980) 1.02
Identification of amino acid substitutions in the dicyclohexylcarbodiimide-binding subunit of the mitochondrial ATPase complex from oligomycin-resistant mutants of Saccharomyces cerevisiae. Eur J Biochem (1979) 1.01
The interleukin-4 receptor activates STAT5 by a mechanism that relies upon common gamma-chain. J Biol Chem (1998) 1.00
Site-directed mutagenesis reveals the importance of disulfide bridges and aromatic residues for structure and proliferative activity of human interleukin-4. FEBS Lett (1991) 0.97
Structure and genetics of the H+-conducting F0 portion of the ATP synthase. Ann N Y Acad Sci (1982) 0.96
Synthesis of a larger precursor for the proteolipid subunit of the mitochondrial ATPase complex of Neurospora crassa in a cell-free wheat germ system. FEBS Lett (1979) 0.95
Inhibition of the assembly of cytochrome oxidase in Neurospora crassa by chloramphenicol. Eur J Biochem (1972) 0.95
Dimerization of signalling modules of the EvgAS and BvgAS phosphorelay systems. Biochim Biophys Acta (2000) 0.94
Cloning and expression of the fbc operon encoding the FeS protein, cytochrome b and cytochrome c1 from the Rhodopseudomonas sphaeroides b/c1 complex. EMBO J (1985) 0.94
The interleukin-4 site-2 epitope determining binding of the common receptor gamma chain. Eur J Biochem (1998) 0.93
Radiation-induced impairment of bone healing can be overcome by recombinant human bone morphogenetic protein-2. J Craniofac Surg (1998) 0.93
Different pool sizes of the precursor polypeptides of cytochrome oxidase from Neurospora crassa. Eur J Biochem (1972) 0.92
Amino acid sequence of the proteolipid subunit of the proton-translocating ATPase complex from the thermophilic bacterium PS-3. Eur J Biochem (1980) 0.92
Rational design of a GCN4-derived mimetic of interleukin-4. Nat Struct Biol (1999) 0.92
Inductive properties of recombinant human BMP-2 produced in a bacterial expression system. Int J Oral Maxillofac Surg (1998) 0.92
Cytokine expression in T-cell lymphomas and Hodgkin's disease. Its possible implication in autocrine or paracrine production as a potential basis for neoplastic growth. Am J Pathol (1991) 0.92
Immunological techniques for studies on the biogenesis of mitochondrial membrane proteins. Methods Biochem Anal (1981) 0.91
Interleukin-6 administration has no acute hemodynamic or hematologic effect in the dog. Cytokine (1991) 0.91
The dicyclohexylcarbodiimide-binding protein of the mitochondrial ATPase complex from beef heart. Isolation and amino acid composition. FEBS Lett (1978) 0.91
The primary structure of cytochrome c1 from Neurospora crassa. Eur J Biochem (1987) 0.91
The impact of the route and frequency of antigen exposure on the IgE response in allergy. Int Arch Allergy Immunol (2001) 0.91
Activation of STAT5 by IL-4 relies on Janus kinase function but not on receptor tyrosine phosphorylation, and can contribute to both cell proliferation and gene regulation. Int Immunol (1999) 0.90
The two subunits of the interleukin-4 receptor mediate independent and distinct patterns of ligand endocytosis. Eur J Biochem (1999) 0.90
Receptor binding properties of four-helix-bundle growth factors deduced from electrostatic analysis. Protein Sci (1994) 0.89
Bone morphogenetic protein 2 (BMP-2) induces sequential changes of Id gene expression in the breast cancer cell line MCF-7. J Cancer Res Clin Oncol (2000) 0.88
Puromycin sensitivity of ribosomal label after incorporation of 14C-labelled amino acids into isolated mitochondria from Neurospora crassa. Eur J Biochem (1969) 0.88
Contribution of mitochondrial and cytoplasmic protein synthesis to the formation of cytochrome b and cytochrome aa3. Biochimie (1973) 0.88
Soluble interleukin-2 receptors inhibit interleukin 2-dependent proliferation and cytotoxicity: explanation for diminished natural killer cell activity in cutaneous T-cell lymphomas in vivo? J Invest Dermatol (1992) 0.86
Upon prolonged allergen exposure IL-4 and IL-4Ralpha knockout mice produce specific IgE leading to anaphylaxis. Int Arch Allergy Immunol (2001) 0.85
The crystal structure of the BMP-2:BMPR-IA complex and the generation of BMP-2 antagonists. J Bone Joint Surg Am (2001) 0.85
Aspects of receptor binding and signalling of interleukin-4 investigated by site-directed mutagenesis and NMR spectroscopy. J Mol Biol (1994) 0.85
Interleukin-4 upregulates the heat shock protein Hsp90alpha and enhances transcription of a reporter gene coupled to a single heat shock element. FEBS Lett (1996) 0.84
Radiation-induced suppression of the Bmp2 signal transduction pathway in the pluripotent mesenchymal cell line C2C12: an in vitro model for prevention of heterotopic ossification by radiotherapy. Radiat Res (2003) 0.84
Sustained release carriers used to delivery bone morphogenetic proteins in the bone healing process. Anat Histol Embryol (2007) 0.83
Purification of cytochrome oxidase from Neurospora crassa and other sources. Methods Enzymol (1978) 0.83
Osteoinductive, morphologic, and biomechanical properties of autolyzed, antigen-extracted, allogeneic human bone. J Oral Maxillofac Surg (1993) 0.83
[Comparison of the osteogenic activity of bone morphogenetic protein (BMP) mutants]. Mund Kiefer Gesichtschir (2005) 0.82
[Effect of different factors on the bone forming properties of recombinant BMPs]. Mund Kiefer Gesichtschir (2000) 0.82
Time kinetics of bone defect healing in response to BMP-2 and GDF-5 characterised by in vivo biomechanics. Eur Cell Mater (2011) 0.82
A single administration of interleukin-4 antagonistic mutant DNA inhibits allergic airway inflammation in a mouse model of asthma. Gene Ther (2003) 0.81
Neutralizing monoclonal antibodies define two different functional sites in human interleukin-4. Eur J Biochem (1994) 0.81
[Biological activity of E. coli expressed BMP-4]. Mund Kiefer Gesichtschir (1998) 0.80
[Cytochrome oxidase and associated with it a labelled protein from 14C-labelled mitochondria of Neurospora crassa]. Hoppe Seylers Z Physiol Chem (1969) 0.79
IL-4 receptor complexes containing or lacking the gamma C chain are inhibited by an overlapping set of antagonistic IL-4 mutant proteins. Int Immunol (1997) 0.79
Cytokine expression in B-cell non-Hodgkin lymphomas. Hematol Oncol (1991) 0.79
A murine interleukin-4 antagonistic mutant protein completely inhibits interleukin-4-induced cell proliferation, differentiation, and signal transduction. J Biol Chem (1997) 0.79
Bone morphogenetic protein-2 and growth and differentiation factor-5 enhance the healing of necrotic bone in a sheep model. Growth Factors (2001) 0.78
A strict requirement of interleukin-4 for interleukin-4 induction in antigen-stimulated human memory T cells. Eur J Immunol (1996) 0.78
The human osteosarcoma cell line U-2 OS expresses a 3.8 kilobase mRNA which codes for the sequence of the PDGF-B chain. FEBS Lett (1986) 0.78
Labeling of individual amino acid residues in the membrane-embedded F0 part of the F1 F0 ATP synthase from Neurospora crassa. Influence of oligomycin and dicyclohexylcarbodiimide. Eur J Biochem (1986) 0.77
Improving the refolding yield of interleukin-4 through the optimization of local interactions. J Biotechnol (2000) 0.77
Transmembrane and intracellular signalling by interleukin-4: receptor dimerization and beyond. Eur Cytokine Netw (1996) 0.77
Antagonist design through forced electrostatic mismatch. Nat Struct Biol (1994) 0.77
Crystals of a 1:1 complex between human interleukin-4 and the extracellular domain of its receptor alpha chain. Eur J Biochem (1998) 0.77
Topological studies suggest that the pathway of the protons through F0 is provided by amino acid residues accessible from the lipid phase. Biochimie (1986) 0.77